Terminated
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
FCAB - ClinicalTrials.gov - NCT03831191
The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).
How long will I be in the trial?
The study will last about 65 weeks and may include up to 18 visits.
Terminated
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
FCAB - ClinicalTrials.gov - NCT03831191
The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).
How long will I be in the trial?
The study will last about 65 weeks and may include up to 18 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must NOT
Trial Summary
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
interventions example
Could I receive a Placebo?
yes
Enrollment Goal
200
Trial Dates
February 2019 - February 2020
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must NOT
Trial Summary
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
interventions example
Could I receive a Placebo?
yes
Enrollment Goal
200
Trial Dates
February 2019 - February 2020
Trial Phase
2
Not the right fit? Sign up to receive updates on new Atopic Dermatitis (Eczema) trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Atopic Dermatitis (Eczema) Resources
